Frisch Financial Group, Inc. Abb Vie Inc. Transaction History

Frisch Financial Group, Inc.

$333 Million
Q3 2024

A detailed history of Frisch Financial Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 7,730 shares of ABBV stock, worth $1.39 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

7,730

Previous 6,920 11.71%

Holding current value

$1.39 Million

Previous $1.19 Million 28.64%

% of portfolio

0.46%

Previous 0.36%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $132,710 - $161,457	810 Added 11.71%	7,730 $1.53 Million
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $8,203 - $9,580	53 Added 0.77%	6,920 $1.19 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $17,260 - $19,666	-108 Reduced 1.55%	6,867 $1.25 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $4,953 - $5,578	36 Added 0.52%	6,975 $1.08 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $18,702 - $21,651	-140 Reduced 1.98%	6,939 $1.03 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $40,415 - $50,294	-305 Reduced 4.13%	7,079 $954,000
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $9,399 - $10,825	65 Added 0.89%	7,384 $1.18 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $138 - $165	1 Added 0.01%	7,319 $1.18 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $31,405 - $36,019	234 Added 3.3%	7,318 $982,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $8,257 - $10,497	60 Added 0.85%	7,084 $1.09 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $161,807 - $200,757	-1,226 Reduced 14.86%	7,024 $1.14 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $19,767 - $25,011	-184 Reduced 2.18%	8,250 $1.11 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $3.7 Million - $4.2 Million	-34,793 Reduced 80.49%	8,434 $910,000
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $3.71 Million - $4.21 Million	34,854 Added 416.27%	43,227 $908,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $17,359 - $19,339	165 Added 2.01%	8,373 $943,000
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $14,833 - $16,329	145 Added 1.8%	8,208 $888,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $25,917 - $34,991	322 Added 4.16%	8,063 $864,000
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $7,817 - $9,175	91 Added 1.19%	7,741 $678,000
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $596,057 - $797,614	-8,124 Reduced 51.5%	7,650 $751,000
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $381,775 - $578,819	5,919 Added 60.06%	15,774 $1.2 Million
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $433,717 - $542,673	6,013 Added 156.51%	9,855 $873,000
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $241,969 - $290,916	3,842 New	3,842 $291,000
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $185,830 - $218,713	-2,409 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $187,540 - $231,288	2,409 New	2,409 $222,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.

Account

Frisch Financial Group, Inc. Abb Vie Inc. Transaction History